Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04863092
Status:
RECRUITING
Last Update Posted:
2023-07-03
First Post:
2021-04-26
Brief Title:
Intervention to Educate and Improve Underrepresented Populations Participation in Clinical Trials
Sponsor:
University of Colorado Denver
Organization:
University of Colorado Denver
Study Overview
Official Title:
Intervention to Educate and Improve Underrepresented Populations Participation in Clinical Trials
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This proposal aims to leverage ongoing community outreach efforts and the Cancer Centers aims to improve recruitment to clinical trials by educating the catchment and making referrals to engage current UCCC patients not taking advantage of available CTs at this institution and affiliated hospitals The Cancer Prevention and Control Program within UCCC works to develop and evaluate novel approaches to primary prevention disseminate preventative interventions in population-based settings and to improve health services delivery and outcomes for cancer patients and survivors A primary emphasis is placed on those from underrepresented populations including Hispanics residents of outlying rural areas and those in areas of poverty Efforts to meet the Cancer Centers priorities include interventions to promote awareness and recruitment of eligible patients to available CTs in the catchment area the state of Colorado
Detailed Description:
Clinical Trial Education Intervention The educational intervention will be delivered to approximately 200 participants by the Community Health Educators CHEs who will conduct workshops to deliver content and educational materials to patients about the importance of participating in cancer clinical trials The workshops will last approximately 60 minutes with 20 minutes to educate participants and 10 minutes to discuss the materials and answer any questions Prior to and after the presentation the CHE will administer the pre- and post-intervention survey to participants Group sizes will be capped to 25 individuals per group
Additionally the CHE andor Patient Navigators PNs will set up pathways for communication with key personnel ie nurse navigators clinical research coordinators investigators from partnering hospitals and clinics to facilitate patient referrals and evaluation for eligibility for clinical trials The CHE andor PN will keep track of those individuals that are referred by the partner hospital and clinics to track if the PN referral resulted in enrollment and participation in a clinical trial The CHE andor PN will also record and report quarterly the number of a persons referred to therapeuticintervention CTs at the UCCC and partnering hospitals b referred persons screened for therapeuticintervention CTs at the UCCC and partnering hospitals creferred persons enrolled in therapeutic intervention CTs at the UCCC and partnering hospitals
Additionally the CHE andor Patient Navigators PNs will set up pathways for communication with key personnel ie nurse navigators clinical research coordinators investigators from partnering hospitals and clinics to facilitate patient referrals and evaluation for eligibility for clinical trials The CHE andor PN will keep track of those individuals that are referred by the partner hospital and clinics to track if the PN referral resulted in enrollment and participation in a clinical trial The CHE andor PN will also record and report quarterly the number of a persons referred to therapeuticintervention CTs at the UCCC and partnering hospitals b referred persons screened for therapeuticintervention CTs at the UCCC and partnering hospitals creferred persons enrolled in therapeutic intervention CTs at the UCCC and partnering hospitals
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P30CA046934 | NIH | None | httpsreporternihgovquickSearchP30CA046934 |